These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2780585)

  • 1. Further studies into the ECG effects of tedisamil (KC 8857) in rats.
    Howard PG; Abraham S; Courtice ID; Walker MJ
    Proc West Pharmacol Soc; 1989; 32():183. PubMed ID: 2780585
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative study of the antiarrhythmic properties of eicosanoid inhibitors, free radical scavengers and potassium channel blockers on reperfusion induced arrhythmias in the rat.
    Beatch GN; Courtice ID; Salari H
    Proc West Pharmacol Soc; 1989; 32():285-9. PubMed ID: 2780604
    [No Abstract]   [Full Text] [Related]  

  • 3. The in vivo electrophysiological actions of the new potassium channel blockers, tedisamil and UK 68,798.
    Beatch GN; MacLeod BA; Abraham S; Walker MJ
    Proc West Pharmacol Soc; 1990; 33():5-8. PubMed ID: 2274546
    [No Abstract]   [Full Text] [Related]  

  • 4. Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells.
    Dukes ID; Cleemann L; Morad M
    J Pharmacol Exp Ther; 1990 Aug; 254(2):560-9. PubMed ID: 2384886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac electrophysiologic and antiarrhythmic actions of tedisamil.
    Wallace AA; Stupienski RF; Baskin EP; Appleby SD; Kothstein T; Gehret JR; King SW; Remy DC; Lynch JJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):168-75. PubMed ID: 7714763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Block by a putative antiarrhythmic agent of a calcium-dependent potassium channel in cultured hippocampal neurons.
    McLarnon JG
    Neurosci Lett; 1990 May; 112(2-3):210-5. PubMed ID: 2359519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blocker.
    Beatch GN; Abraham S; MacLeod BA; Yoshida NR; Walker MJ
    Br J Pharmacol; 1991 Jan; 102(1):13-8. PubMed ID: 2043919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined administration of an IK(ATP) activator and Ito blocker increases coronary flow independently of effects on heart rate, QT interval, and ischaemia-induced ventricular fibrillation in rats.
    Rees SA; Tsuchihashi K; Hearse DJ; Curtis MJ
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):343-9. PubMed ID: 7504122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tedisamil (KC 8857) differentially inhibits the 86Rb+ efflux-stimulating and vasorelaxant properties of cromakalim.
    Bray K; Quast U
    Eur J Pharmacol; 1991 Jul; 200(1):163-5. PubMed ID: 1769368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actions of cardiac drugs on a calcium-dependent potassium channel in hippocampal neurons.
    McLarnon JG; Wang XP
    Mol Pharmacol; 1991 Apr; 39(4):540-6. PubMed ID: 2017153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tedisamil inactivates transient outward K+ current in rat ventricular myocytes.
    Dukes ID; Morad M
    Am J Physiol; 1989 Nov; 257(5 Pt 2):H1746-9. PubMed ID: 2556052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tedisamil blocks a calcium-dependent potassium channel in cultured motoneurons.
    McLarnon JG; Sawyer D; Michikawa M; Kim SU
    Neurosci Lett; 1992 Sep; 144(1-2):185-8. PubMed ID: 1436700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KC 9172 (free base of KC 7218)--an antipsychotic/anxiolytic compound. I. Antipsychotic and anxiolytic activity in comparison with chlorpromazine, clozapine, diazepam and buspirone.
    Ruhland M; Krähling H; Fuchs A; Schön U
    Pharmacopsychiatry; 1988 Nov; 21(6):396-8. PubMed ID: 2907649
    [No Abstract]   [Full Text] [Related]  

  • 14. KC 9172 (free base of KC 7218)--an antipsychotic/anxiolytic compound. II. Discrimination from typical neuroleptics and benzodiazepine-like minor tranquilizers.
    Krähling H; Fuchs A; Ruhland M; Schön U; Mol F; Tulp M
    Pharmacopsychiatry; 1988 Nov; 21(6):399-401. PubMed ID: 2907650
    [No Abstract]   [Full Text] [Related]  

  • 15. Tedisamil. KC 8857.
    Drugs R D; 1999 Apr; 1(4):327-30. PubMed ID: 10566055
    [No Abstract]   [Full Text] [Related]  

  • 16. Actions and interactions of E-4031 and tedisamil on reperfusion-induced arrhythmias and QT interval in rat in vivo.
    Bril A; Landais L; Gout B
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):233-40. PubMed ID: 8357777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of E-4031, almokalant and tedisamil on postrest action potential duration of human papillary muscles.
    Ohler A; Ravens U
    J Pharmacol Exp Ther; 1994 Aug; 270(2):460-5. PubMed ID: 7520940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of high-affinity synaptosomal uptake of gamma-aminobutyric acid by a bicyclo-heptane derivative.
    Kovács I; Maksay G; Simonyi M
    Arzneimittelforschung; 1989 Mar; 39(3):295-7. PubMed ID: 2502985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolongation of monophasic action potential duration and the refractory period in the human heart by tedisamil, a new potassium-blocking agent.
    Bargheer K; Bode F; Klein HU; Trappe HJ; Franz MR; Lichtlen PR
    Eur Heart J; 1994 Oct; 15(10):1409-14. PubMed ID: 7821321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cardiovascular and antiarrhythmic properties of a series of novel sparteine analogs.
    Pugsley MK; Walker MJ; Garrison GL; Howard PG; Lazzara R; Patterson E; Penz WP; Scherlag BJ; Berlin KD
    Proc West Pharmacol Soc; 1992; 35():87-91. PubMed ID: 1323855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.